intranasal glutathione in parkinson& 39 Innovative approach Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Targets to Search for New
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single Neuron Degeneration Model Nose to brain drug delivery: from bench to bedside PMC Nanotechnology based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders ScienceDirect Intranasal delivery of rotigotine to the brain for treating Parkinson's disease ScienceDirect Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy Drug Delivery and Translational Research Springer Nature Link
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




